ArticlePLoS computational biology2026

Using cell-specific late-phase asthma mRNA biomarkers to repurpose drugs that concurrently reverse disease signatures across multiple immune cell-types.

Mingming Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.